Endpoints News ٦ أبريل ٢٠٢٦ Stipple Bio launches with $100M to find more precise targets on cancer proteins
Endpoints News ١١ فبراير ٢٠٢٦ Upstream Bio says verekitug delivered positive data in Phase 2 severe asthma trial
Endpoints News ٩ ديسمبر ٢٠٢٥ Stealthy biotech Sidera Bio raises $109M; Assembly's data for oral herpes drugs
Endpoints News ١ ديسمبر ٢٠٢٥ Belite Bio aims for first approval of Stargardt disease treatment with Phase 3 success